{"id":1333584,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-08","captureTimestamp":"2026-03-08T19:38:56.693000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/1333584","browseUrl":"https://replay.healtharchive.ca/job-8/20260308193856/https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true#ha_snapshot=1333584","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}